Algorics and ADAMAS Announce Strategic Partnership and Release Platform
Houston, TX, USA, June 12, 2017. Algorics, a provider of clinical analytics solutions and software for the global life sciences industry, announced a partnership with life sciences Quality Assurance Consultants, ADAMAS. Under the partnership ADAMAS will make available to clients their comprehensive proprietary audit metrics data via the Acuity platform.
In announcing the partnership, Algorics Chief Commercial Officer Rob Nichols said “There is an increasing requirement of the bio-pharma industry to better understand, and extract value from, the huge volume and variety of increasingly complex data being collected during business as normal. We are delighted that ADAMAS is now able to provide a comprehensive view of data collected from audits allowing their clients to benchmark the quality of their studies against anonymized competitors, thus allowing them to improve the strategic focus of their QA activities.”
Dr. Patricia Fitzgerald, ADAMAS Chief Executive Officer stated “Provision of the audit metrics and benchmarking data to our clients, is just one example of the ADAMAS ethos for informing our clients decisions, allowing them to achieve the best outcomes when considering their clinical quality assurance strategy.”
Algorics and ADAMAS will be demonstrating how Acuity is helping drive next generation auditing at the DIA 2017 Annual Meeting in Chicago, IL from June 18-22 where you can join them at booth 1352.
About
Algorics brings together a team of highly experienced software and life sciences professionals, united behind a single goal: to provide innovative risk based monitoring and clinical analytics solutions and software to the global life sciences industry with consistent and reliable quality. For more information about Algorics and Acuity visit: www.algorics.com
ADAMAS was established in 1997 to provide independent quality assurance, quality management, and training to the healthcare industry. ADAMAS is one of the largest QA consultancy organizations in the world and is well respected within the healthcare industry. We understand our clients’ needs and strive to provide cost-effective services of the highest value. With a diverse set of QA capabilities, ADAMAS is capable of managing both small and large complex QA projects. For more information about ADAMAS visit: www.adamasconsulting.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
